Last year, the U.S. Food and Drug Administration (FDA) approved a pill that is integrated with an ingestible sensor that captures information about whether the patient has complied with her medication regimen.
The #WeDiDiT (Wellthy Digital Diabetes Therapy) trial is all set to prove the efficacy of its 16-week structured diabetes management programme delivered through a mobile app.